Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learning.

Journal: eLife
PMID:

Abstract

Gait is impaired in musculoskeletal conditions, such as knee arthropathy. Gait analysis is used in clinical practice to inform diagnosis and monitor disease progression or intervention response. However, clinical gait analysis relies on subjective visual observation of walking as objective gait analysis has not been possible within clinical settings due to the expensive equipment, large-scale facilities, and highly trained staff required. Relatively low-cost wearable digital insoles may offer a solution to these challenges. In this work, we demonstrate how a digital insole measuring osteoarthritis-specific gait signatures yields similar results to the clinical gait-lab standard. To achieve this, we constructed a machine learning model, trained on force plate data collected in participants with knee arthropathy and controls. This model was highly predictive of force plate data from a validation set (area under the receiver operating characteristics curve [auROC] = 0.86; area under the precision-recall curve [auPR] = 0.90) and of a separate, independent digital insole dataset containing control and knee osteoarthritis subjects (auROC = 0.83; auPR = 0.86). After showing that digital insole-derived gait characteristics are comparable to traditional gait measurements, we next showed that a single stride of raw sensor time-series data could be accurately assigned to each subject, highlighting that individuals using digital insoles can be identified by their gait characteristics. This work provides a framework for a promising alternative to traditional clinical gait analysis methods, adds to the growing body of knowledge regarding wearable technology analytical pipelines, and supports clinical development of at-home gait assessments, with the potential to improve the ease, frequency, and depth of patient monitoring.

Authors

  • Matthew F Wipperman
    Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Allen Z Lin
    Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Kaitlyn M Gayvert
    Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Benjamin Lahner
    Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Selin Somersan-Karakaya
    Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Xuefang Wu
    Guizhou Provincial People's Hospital, Guizhou University, Guiyang 550002, China.
  • Joseph Im
    Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Minji Lee
  • Bharatkumar Koyani
    Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Ian Setliff
    Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Malika Thakur
    Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Daoyu Duan
    Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Aurora Breazna
    Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Fang Wang
    Key Laboratory of Intelligent Computing and Information Processing of Ministry of Education and Hunan Key Laboratory for Computation and Simulation in Science and Engineering, Xiangtan University, Xiangtan, China.
  • Wei Keat Lim
    Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Gabor Halasz
    Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Jacek Urbanek
    Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Yamini Patel
    General Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Gurinder S Atwal
    Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States.
  • Jennifer D Hamilton
    Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Samuel Stuart
  • Oren Levy
    Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.
  • Andreja Avbersek
    Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Rinol Alaj
    Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Sara C Hamon
    Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
  • Olivier Harari
    Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.